NO20005725L - Biologisk aktiv sammensetning - Google Patents

Biologisk aktiv sammensetning

Info

Publication number
NO20005725L
NO20005725L NO20005725A NO20005725A NO20005725L NO 20005725 L NO20005725 L NO 20005725L NO 20005725 A NO20005725 A NO 20005725A NO 20005725 A NO20005725 A NO 20005725A NO 20005725 L NO20005725 L NO 20005725L
Authority
NO
Norway
Prior art keywords
biologically active
active agent
carrier
chemical operation
active composition
Prior art date
Application number
NO20005725A
Other languages
English (en)
Other versions
NO20005725D0 (no
Inventor
Aake Lindahl
Haakan Hagslaett
Catharina Benediktsson
Rickard Bryland
Original Assignee
Bioglan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan Ab filed Critical Bioglan Ab
Publication of NO20005725D0 publication Critical patent/NO20005725D0/no
Publication of NO20005725L publication Critical patent/NO20005725L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Oppfinnelsen vedrører en ny biologisk aktiv blanding som omfatter et biologisk aktivt middel som skal frigis derfra, hvor det biologisk aktive middel oppløses og/eller dispergeres i en overmettet tilstand inne i en bærer, idet bæreren er en flytende og/eller fast ikke-krystallinsk matriks, og hvor utfellingen av det biologisk aktive middel er vesentlig eller fullstendig inhibert deri. Den nevnte overmettede tilstand er oppnåelig ved at en eller flere bærer-utgangssubstanser underkastes slik kjemisk operasjon eller operasjoner at det tilveiebringes en matriks hvori metningsgraden av det biologisk aktive middel er høyere enn metningsgraden av det biologisk aktive middel i bærer- utgangssubstansen eller substansene, idet det biologisk aktive middel tilsettes enten før den eller de nevnte kjemiske operasjoner eller etter et forut bestemt tidspunkt, hvoretter den således fremstilte blanding videre underkastes den eller de nevnte kjemiske operasjoner.
NO20005725A 1998-05-14 2000-11-13 Biologisk aktiv sammensetning NO20005725L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801705A SE9801705D0 (sv) 1998-05-14 1998-05-14 Biologically active composition
PCT/SE1999/000824 WO1999058109A1 (en) 1998-05-14 1999-05-12 Biologically active composition

Publications (2)

Publication Number Publication Date
NO20005725D0 NO20005725D0 (no) 2000-11-13
NO20005725L true NO20005725L (no) 2001-01-11

Family

ID=20411319

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005725A NO20005725L (no) 1998-05-14 2000-11-13 Biologisk aktiv sammensetning

Country Status (20)

Country Link
EP (1) EP1077677B1 (no)
JP (1) JP2002514588A (no)
KR (1) KR100766998B1 (no)
CN (1) CN1309554A (no)
AT (1) ATE252371T1 (no)
AU (1) AU742921B2 (no)
CA (1) CA2332110A1 (no)
DE (2) DE69912271T2 (no)
DK (1) DK1077677T3 (no)
ES (1) ES2155049T3 (no)
GR (1) GR20010300014T1 (no)
HU (1) HUP0102002A3 (no)
IL (2) IL139577A0 (no)
NO (1) NO20005725L (no)
NZ (1) NZ508074A (no)
PL (1) PL344221A1 (no)
SE (1) SE9801705D0 (no)
TR (1) TR200003588T2 (no)
WO (1) WO1999058109A1 (no)
ZA (1) ZA200006476B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064149A1 (en) * 2000-02-29 2001-09-07 Jie Zhang Improved transdermal drug patch
MXPA06001401A (es) 2003-08-06 2006-05-19 Nirmal Mulye Composicion farmaceutica que contiene farmaco soluble en agua.
AU2007260739A1 (en) 2006-06-14 2007-12-21 Dr. Reddy's Laboratories Limited Topical compositions
JP2013536884A (ja) * 2010-08-31 2013-09-26 ビーエーエスエフ ソシエタス・ヨーロピア クエン酸に基づいた分枝ポリエステル、さらにはそれらの製造及び使用
EP2663285A2 (en) * 2011-01-13 2013-11-20 Qlt Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
HUP0102002A3 (en) 2002-12-28
ZA200006476B (en) 2001-06-11
IL139577A0 (en) 2002-02-10
AU4405199A (en) 1999-11-29
EP1077677A1 (en) 2001-02-28
GR20010300014T1 (en) 2001-04-30
ATE252371T1 (de) 2003-11-15
DE69912271D1 (de) 2003-11-27
JP2002514588A (ja) 2002-05-21
DE69912271T2 (de) 2004-08-26
PL344221A1 (en) 2001-10-08
TR200003588T2 (tr) 2001-06-21
SE9801705D0 (sv) 1998-05-14
HUP0102002A2 (hu) 2002-03-28
KR100766998B1 (ko) 2007-10-15
DK1077677T3 (da) 2004-02-16
CN1309554A (zh) 2001-08-22
CA2332110A1 (en) 1999-11-18
AU742921B2 (en) 2002-01-17
DE1077677T1 (de) 2001-09-20
ES2155049T3 (es) 2004-05-16
KR20010052349A (ko) 2001-06-25
ES2155049T1 (es) 2001-05-01
EP1077677B1 (en) 2003-10-22
NZ508074A (en) 2003-01-31
IL139577A (en) 2007-07-04
WO1999058109A1 (en) 1999-11-18
NO20005725D0 (no) 2000-11-13

Similar Documents

Publication Publication Date Title
Pommier et al. The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nuclei
DK0833611T3 (da) Sammensætning omfattende et aktivt middel opløst i en glasdannende bærer og fremgangsmåde til fremstilling heraf
CL2010001333A1 (es) Metodo para cristalizar en estado solido particulas esfericas de una mezcla de dos o mas compuestos organicos alotropicos, obtenidas por fusion-pulverizacion y congelamiento, que incluye someter a dichas particulas a una atmosfera que contiene vapores de solvente (divisional de sol. 213-99).
SE8105897L (sv) Sett for mikroinkapsling
ATE253620T1 (de) Farbmittelzubereitungen
BR0112616A (pt) Método para tratar, múltiplos intervalos de uma ou mais formações subterrâneas interceptadas por um furo de poço revestido
PT1133284E (pt) Um processo para a preparacao de particulas cristalinas
NO970610L (no) Sammensetning for selektiv frigjöring av en aktiv ingrediens
ATE253820T1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
NO20005725L (no) Biologisk aktiv sammensetning
ATE310500T1 (de) Biologisch aktive zusammensetzung
US5994407A (en) Procedure to prepare a solution with capsaicin
TR199901044T2 (en) Endos�lfan-mikrokaps�l da��l�m�.
JPS5320656A (en) Method of decoloring colored waste water
Bownds et al. In vitro physiology of frog photoreceptor membranes
KR910000540A (ko) 물을 처리하는 방법
Mulligan et al. Mechanism of dissolution of cholesterol‐calcium bilirubinate compressed discs in monooctanoin
Singh Monoamine oxidase inhibitors and the depletion of 5-hydroxytryptamine from enterochromaffin cells by reserpine
KR0130540B1 (en) Repellent composition containing porous alumina silica
Vaughan Effects of choleragen and fluoride on adenylate cyclase
KR960029252A (ko) 수처리제 조성물
KR910002493A (ko) 다공질화산암(多孔質火山岩)을 활용한 공해방지제 (公害防止劑)의 제조방법
NO983373L (no) Medikamentsystem for konstituering in situ for frigjöring av enzymer i sår
EP0667153A4 (en) PROCESS FOR THE PREPARATION OF A COMPOSITION FOR A SOLID MEDICAMENT.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application